TECX
Tectonic Therapeutic, Inc.
Tectonic Therapeutic, Inc. (TECX) has 6 SEC Form 4 filings (10 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 1, 2026.
The most active filer is Chief Medical Officer Ruddy Marcella K. with 3 filings. Insiders have net sold $558K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Alise S. Reicin
- Employees:51
- HQ:Watertown, MA, US
- IPO:2018-06-21
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$558K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$536.5M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
McNamara PeterFirst in 4 months | Chief Scientific Officer | Sale | 172 | $6K | Jul 1 | SEC ↗ |
| Chief Medical Officer | Sale | 1,065 | $32K | May 6 | SEC ↗ | |
| Chief Medical Officer | Sale | 1,000 | $31K | Apr 3 | SEC ↗ | |
McNamara PeterFirst filing | Chief Scientific Officer | Sale | 6,262 | $189K | Mar 9 | SEC ↗ |
Ruddy Marcella K.First filing | Chief Medical Officer | Sale | 10,000 | $300K | Mar 9 | SEC ↗ |
Related companies
Tectonic Therapeutic, Inc. is in the Healthcare sector.